Spoken Alpha
FOXO TECHNOLOGIES INC.
FOXO Technologies operates three healthcare and life science divisions: a rural hospital and behavioral health services division providing substance use disorder treatment and emergency care in Tennessee; a biospecimen sourcing and distribution division serving pharmaceutical and biotechnology research; and an epigenetics diagnostics division developing saliva-based biomarker technology for health and wellness applications.
FOXO TECHNOLOGIES INC is a Healthcare company operating in Medical Care Facilities with a $212,006 market cap.
Most recent reported earnings: Q3 FY2025 (Nov 9, 2025).
Behavioral analysis
Disclosures
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add FOXO, reply to your welcome email and we'll prioritize it.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for FOXO.
$ curl https://api.spokenalpha.com/v1/companies/FOXOFAQ
Spoken Alpha indexes FOXO's earnings call transcripts at https://spokenalpha.com/companies/FOXO. Each call links to attributed speakers and parsed analyst Q&A.
FOXO TECHNOLOGIES INC. (FOXO) operates in the Healthcare sector (Medical Care Facilities industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2025 | 2025-11-09 | $-0.29 | $0.00 | — | $3.5M | — | — | EODHD |
| Q2 FY2025 | 2025-08-18 | $-0.21 | — | — | $5.2M | — | — | EODHD |
| Q1 FY2025 | 2025-06-25 | $-0.37 | — | — | $3.2M | — | — | EODHD |
| Q4 FY2024 | 2024-12-30 | $-7.21 | — | — | $2.8M | — | — | EODHD |
| Q3 FY2024 | 2024-09-29 | $-3.08 | — | — | $1.2M | — | — | EODHD |
| Q2 FY2024 | 2024-08-18 | $-0.24 | — | — | $28.0K | — | — | EODHD |
| Q1 FY2024 | 2024-06-27 | $-0.24 | — | — | $7.0K | — | — | EODHD |
| Q4 FY2023 | 2023-12-30 | $-10.04 | — | — | $10.0K | — | — | EODHD |
| Q3 FY2023 | 2023-12-28 | $-7.50 | — | — | $10.0K | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-0.49 | — | — | $12.0K | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-0.33 | — | — | $13.0K | — | — | EODHD |
| Q4 FY2022 | 2023-03-29 | $-0.34 | $0.00 | — | $418.0K | — | — | EODHD |
| Q3 FY2022 | 2022-11-20 | $-6.70 | — | — | $14.0K | — | — | EODHD |
| Q2 FY2022 | 2022-08-11 | $-0.01 | — | — | $39.0K | — | — | EODHD |
| Q1 FY2022 | 2022-05-15 | $-0.01 | — | — | $40.0K | — | — | EODHD |
| Q4 FY2021 | 2022-03-06 | $0.04 | — | — | $27.0K | — | — | EODHD |
| Q3 FY2021 | 2021-11-14 | $0.06 | — | — | $31.0K | — | — | EODHD |
| Q2 FY2021 | 2021-08-15 | $-0.33 | — | — | $20.0K | — | — | EODHD |
| Q1 FY2021 | 2021-05-16 | $0.88 | — | — | $42.0K | — | — | EODHD |
| Q4 FY2020 | 2021-03-30 | $0.00 | $0.00 | — | — | — | — | EODHD |
Source: EODHD. FOXO reported actuals as published; sparse fields render as —.